Walgreens Boots Alliance Inc. (NASDAQ:WBA) went up by 2.20% from its latest closing price compared to the recent 1-year high of $53.46. The company’s stock price has collected -0.30% of loss in the last five trading sessions. The Wall Street Journal reported on 01/05/23 that Walgreens Sales Fall as Demand for Covid Vaccines Wanes
Is It Worth Investing in Walgreens Boots Alliance Inc. (NASDAQ :WBA) Right Now?
Plus, the 36-month beta value for WBA is at 0.74. Opinions of the stock are interesting as 2 analysts out of 19 who provided ratings for Walgreens Boots Alliance Inc. declared the stock was a “buy,” while 1 rated the stock as “overweight,” 14 rated it as “hold,” and 1 as “sell.”
The average price from analysts is $41.36, which is $4.8 above the current price. WBA currently public float of 714.48M and currently shorts hold a 4.21% ratio of that float. Today, the average trading volume of WBA was 6.58M shares.
WBA’s Market Performance
WBA stocks went down by -0.30% for the week, with a monthly drop of -7.24% and a quarterly performance of 9.92%, while its annual performance rate touched -31.05%. The volatility ratio for the week stands at 2.17% while the volatility levels for the past 30 days are set at 2.42% for Walgreens Boots Alliance Inc. The simple moving average for the period of the last 20 days is -0.85% for WBA stocks with a simple moving average of -5.87% for the last 200 days.
Analysts’ Opinion of WBA
Many brokerage firms have already submitted their reports for WBA stocks, with Morgan Stanley repeating the rating for WBA by listing it as a “Underweight.” The predicted price for WBA in the upcoming period, according to Morgan Stanley is $39 based on the research report published on November 23rd of the previous year 2022.
Cowen, on the other hand, stated in their research note that they expect to see WBA reach a price target of $54, previously predicting the price at $43. The rating they have provided for WBA stocks is “Outperform” according to the report published on November 22nd, 2022.
JP Morgan gave a rating of “Overweight” to WBA, setting the target price at $42 in the report published on November 18th of the previous year.
WBA Trading at -6.07% from the 50-Day Moving Average
After a stumble in the market that brought WBA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -31.40% of loss for the given period.
Volatility was left at 2.42%, however, over the last 30 days, the volatility rate increased by 2.17%, as shares sank -5.00% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -4.23% lower at present.
During the last 5 trading sessions, WBA fell by -0.30%, which changed the moving average for the period of 200-days by -15.68% in comparison to the 20-day moving average, which settled at $36.89. In addition, Walgreens Boots Alliance Inc. saw -1.85% in overturn over a single year, with a tendency to cut further losses.
Reports are indicating that there were more than several insider trading activities at WBA starting from Walgreens Boots Alliance, Inc., who sale 5,961,534 shares at the price of $165.08 back on Dec 08. After this action, Walgreens Boots Alliance, Inc. now owns 33,659,180 shares of Walgreens Boots Alliance Inc., valued at $984,130,033 using the latest closing price.
Ban Kevin M., the EVP, Chief Medical Officer of Walgreens Boots Alliance Inc., sale 10,303 shares at $40.19 during a trade that took place back on Nov 18, which means that Ban Kevin M. is holding 27,916 shares at $414,108 based on the most recent closing price.
Stock Fundamentals for WBA
Current profitability levels for the company are sitting at:
- +2.09 for the present operating margin
- +19.80 for the gross margin
The net margin for Walgreens Boots Alliance Inc. stands at +3.27. Equity return is now at value -12.00, with -3.20 for asset returns.
The liquidity ratio also appears to be rather interesting for investors as it stands at 0.75.